Eli Lilly and Company Ltd

Large enterpriseUK · BasingstokeCompany No. 00284385

Eli Lilly and Company Ltd is a UK limited company, based in Basingstoke, incorporated in 1934. Has won 49 UK public-sector contracts worth £107.7m across 5 buyers, primarily NHS England.

⇄ Compare peers ⇩ Export ↗ Share

Active contracts

no new awards in 30d

Contracted (12m)

—

no data

Public buyers

stable this month

Top buyer share

100%

NHS England

Buyer concentration

Each block sized by share of total award value. A dominant block signals dependency on one buyer.

Severe concentration. Top buyer alone = 100% of revenue.

NHS England

£107.7m

100%

eTenderwales

—

The NHS Commissioning Board (operating under the name of NHS England)

—

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

—

BELFAST HEALTH AND SOCIAL CARE TRUST

—

Contracts won · 49 total · 37 active · 12 expired

Every contract award published under the Procurement Act.

Sort

Title	Buyer	Award type	Value	Awarded	Status
NHS Framework Agreement - North of England - Tranche B	NHS England	Framework call off	£17.4m ceiling · ~£579k share (÷30)	08 Jan 2018	expired
NHS England Framework Agreement - London - Tranche A	NHS England	Framework call off	£10.6m ceiling · ~£529k share (÷20)	15 Aug 2018	expired
NHS England - Midlands and East Branded Medicines - Tranche B	NHS England	Framework call off	£9.2m ceiling · ~£288k share (÷32)	17 Jan 2019	expired
NHS England - Midlands and East Branded Medicines - Tranche B	NHS England	Framework call off	£9.2m ceiling · ~£288k share (÷32)	17 Jan 2019	expired
NHS England - Midlands and East Branded Medicines - Tranche B	NHS England	Framework call off	£9.2m ceiling · ~£288k share (÷32)	17 Jan 2019	expired
NHS England - Midlands and East Branded Medicines - Tranche B	NHS England	Framework call off	£9.2m ceiling · ~£288k share (÷32)	17 Jan 2019	expired
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity	NHS England	Framework call off	£8.4m ceiling · ~£280k share (÷30)	05 Jul 2019	expired
NHS Framework agreement for Branded Medicines - North of England - Tranche A	NHS England	Framework call off	£8.2m ceiling · ~£327k share (÷25)	18 Feb 2019	expired
NHS England Framework Agreement: Midlands and East (Tranche A)	NHS England	Framework call off	£7.4m ceiling · ~£337k share (÷22)	08 Jan 2018	expired
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice	NHS England	Framework call off	£7.2m ceiling · ~£278k share (÷26)	01 Aug 2019	expired
NHS National Branded Proprietary Products (Interim Agreement) - Contracts Finder Award	NHS England	Framework call off	£6.1m ceiling · ~£673k share (÷9)	01 May 2020	expired
NHS Framework Agreement - North of England - Tranche B	NHS England	Framework call off	£5.6m ceiling · ~£159k share (÷35)	13 Feb 2020	expired
Biologic and Biosimilar Medicines	eTenderwales	Direct contract	—	—	active
NHS Branded Medicines Tranche Framework for London and South of England	NHS England	Direct contract	—	—	active
NHS Branded Medicines Tranche Framework for London and South of England	NHS England	Direct contract	—	—	active

Showing 1–15 of 49

Eli Lilly and Company Ltd

Buyer concentration

Contracts won · 49 total · 37 active · 12 expired

Top buyers · by total award value

Category mix — CPV divisions

Geographic spread

Modifications received · scope growth on existing wins

Compliance scorecard

Financial health

Company information

Corporate structure

Companies House data

Peer suppliers

News mentions

Compliance scorecard

Financial health

Company information

Corporate structure

Eli Lilly and Company Ltd

Companies House data

Why Capita's public-sector share keeps slipping — and who's eating it

The 12 frameworks Capita bid on last year (and lost 8)

Is BPO concentration back? A supplier-risk deep-dive